ECONOMIC ASPECTS OF TREATMENT AND MANAGEMENT OF CLOSTRIDIOIDES DIFFICILE INFECTIONS IN UNIVERSITY CLINICAL HOSPITAL MOSTAR

Abstract

Treatment of Clostridioides difficile infections in University Clinical Hospital Mostar from an economic perspective Clostridioides difficile is the most prominent pathogen directly tied to a healthcare system and proven to be one of the main causes of high economic impacts. It results in a frequent need for hospitalization, including the treatment of sepsis and post-acute care, and requires an extended number of days spent at the hospital. In addition to the costs of the medicine and laboratory analysis, extended hospitalization is the key component of the high healthcare expenses. The rational use of antibiotics, mandatory implementation of general hygiene measures, like washing hands, and disinfecting surfaces can significantly contribute towards hospital's overall expenses. This is particularly important for those in contact with an infected patient or with a patient suspected of having CDI. These basic measures establish security systems in the prevention of CDI. Proper managing and forecasting of the costs on the annual level for each individual healthcare institution is a necessary measure. Developing an accurate estimate of the funds needed for the treatment and prevention of CDI and its best therapies for each form of the disease, is a secure way to prevent recurring episodes that cause a significant economic burden on healthcare institutions.